Cost-effectiveness of adjuvant chemotherapy in early stage breast cancer

被引：0
|
作者：
John, Preethi [1 ]
Bannuru, Raveendhara R. [1 ]
Cohen, Joshua T. [1 ]
Buchsbaum, Rachel J. [1 ]
Erban, John Kalil [1 ]
机构：
[1] Tufts Med Ctr, Boston, MA 02111 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e18887
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18887
引用
收藏
页数：2
相关论文
共 50 条
  • [41] CAPOX VERSUS MFOLFOX AS ADJUVANT CHEMOTHERAPY IN PATIENTS WITH STAGE 3 COLON CANCER: A COST-EFFECTIVENESS STUDY
    Abuloha, S.
    Li, P.
    Bian, J.
    Guo, Y.
    Shao, H.
    VALUE IN HEALTH, 2022, 25 (07) : S370 - S370
  • [42] Modeling the Cost-Effectiveness of Adjuvant Chemotherapy for Stage III Colon Cancer in South African Public Hospitals
    Pumpalova, Yoanna
    Rogers, Alexandra M.
    Tan, Sarah Xinhui
    Herbst, Candice-lee
    Ruff, Paul
    Neugut, Alfred I.
    Hur, Chin
    JCO GLOBAL ONCOLOGY, 2021, 7 : 1730 - 1741
  • [43] Cost-effectiveness of adjuvant chemotherapy with uracil-tegafur for curatively resected stage III rectal cancer
    Hisashige, A.
    Yoshida, S.
    Kodaira, S.
    BRITISH JOURNAL OF CANCER, 2008, 99 (08) : 1232 - 1238
  • [44] MODEL-BASED EFFECTIVENESS AND COST-EFFECTIVENESS OF PERSONALIZED SELECTION STRATEGIES FOR ADJUVANT CHEMOTHERAPY IN STAGE II COLON CANCER
    Jongeneel, Gabrielle
    Greuter, Marjolein J. E.
    van Erning, Felice N.
    Koopman, Miriam
    Vink, Geraldine R.
    Punt, Cornelis J. A.
    Coupe, Veerle M. H.
    MEDICAL DECISION MAKING, 2020, 40 (01) : E80 - E81
  • [45] Adjuvant chemotherapy in patients with resectable stage III colon cancer: lifetime cost-effectiveness and cost-utility analysis
    Bonistalli, L
    Bardelli, F
    Costantini, M
    Trallori, G
    d'Albasio, G
    Messori, A
    CANCER JOURNAL - FRANCE, 1998, 11 (01): : 39 - 47
  • [46] Cost-effectiveness of adjuvant chemotherapy for high-risk stage II and stage III colon cancer in South Africa
    Tan, Sarah Xinhui
    Pumpalova, Yoanna
    Rogers, Alexandra M. M.
    Bhatt, Kishan
    Herbst, Candice-lee
    Ruff, Paul
    Neugut, Alfred I. I.
    Hur, Chin
    CANCER MEDICINE, 2023, 12 (14): : 15515 - 15529
  • [47] COST-EFFECTIVENESS OF 1-YEAR ADJUVANT TRASTUZUMAB THERAPY FOR EARLY STAGE OF HER2-POSITIVE BREAST CANCER
    Nguyen, T. T. T.
    Yagudina, R.
    Kulikov, A. U.
    VALUE IN HEALTH, 2011, 14 (03) : A165 - A165
  • [48] Cost-Effectiveness Analysis of Adjuvant Neratinib Following Trastuzumab in Early-Stage HER2-Positive Breast Cancer
    Tran, Phuong T.
    Diaby, Vakaramoko
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2020, 26 (02): : 221 - 221
  • [49] Cost-Effectiveness Analysis of Adjuvant Neratinib Following Trastuzumab in Early-Stage HER2-Positive Breast Cancer
    Schwartz, Naomi R. M.
    Flanagan, Meghan R.
    Babigumira, Joseph B.
    Steuten, Lotte M.
    Roth, Joshua A.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2019, 25 (10): : 1133 - 1139
  • [50] Cost-Effectiveness Analysis of Intraoperative Radiation Therapy for Early-Stage Breast Cancer
    Michael D. Alvarado
    Aron J. Mohan
    Laura J. Esserman
    Catherine C. Park
    Brittany L. Harrison
    Rebecca J. Howe
    Cristina Thorsen
    Elissa M. Ozanne
    Annals of Surgical Oncology, 2013, 20 : 2873 - 2880
12345